Early Detection Challenges
The conversation dives into the current limitations of early detection methods for conditions like Alzheimer's, highlighting the lack of clinically approved tests and the high costs associated with advanced imaging. Insights reveal that while behavioral and lifestyle changes are crucial for managing chronic health issues, the existing healthcare system often fails to provide the necessary ongoing support and coaching for patients. The discussion also touches on the potential for better preventative approaches in other countries.In this clip
From this podcast
Mind Pump Podcast
Demystifying Alzheimers: Max Lugavere's New Film & Personal Journey | Mind Pump 2370
Related Questions
How do biomarkers relate to Alzheimer's disease in the episode #236 ‒ Neurodegenerative disease: pathology, screening, and prevention | Kellyann Niotis, M.D. and the clip Early Disease Prevention?
How can biomarkers help in the prevention of diseases like Alzheimer's and Parkinson's as discussed in the episode #236 ‒ Neurodegenerative disease: pathology, screening, and prevention | Kellyann Niotis, M.D. and the clip Diagnosing and Treating Neurodegenerative Disease?
Are there any biomarkers predictive or useful for Parkinson's, Alzheimer's, or dementia as discussed in the episode #236 ‒ Neurodegenerative disease: pathology, screening, and prevention | Kellyann Niotis, M.D. and the clip Early Disease Prevention?